# Dopamine Action on Metabolism in Relation to Genotype

> **NCT03525002** · PHASE2 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 120 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Bromocriptine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03525002
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-03
- **Primary completion:** 2024-08-14
- **Final completion:** 2024-08-14
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03525002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03525002, "Dopamine Action on Metabolism in Relation to Genotype". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03525002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*